Nodality inks deal with Pfizer for targeted drugs, diagnostics; Rosetta Genomics raises $27.5M;

@FierceMedDev: China's medical imaging market should exceed $2.5 billion by 2016, a new analysis concludes. Release | Follow @FierceMedDev

 @MarkHFierce: Given Imaging experienced a mixed Q2. Meanwhile, the company is winding up for two regulatory submissions. More | Follow @MarkHFierce

 @DamianFierce: In Q2, Alere's big revenue boost was negated by charges and costs related to its Dx recall. More  | Follow @DamianFierce

> Diagnostics firm Nodality has partnered with Pfizer in a multi-year deal, allowing the pharma giant to use its cellular profiling technology to develop new drugs. Neither party disclosed the financial terms of the agreement, but Pfizer also holds the option of developing companion diagnostics with Nodality. Article

> Berlin Heart is touting a new study of its pump designed to prolong the lives of children waiting on heart transplants. In results published in The New England Journal of Medicine, the device significantly boosted patients' survival rates. News

> NeuWave Medical, a tumor ablation startup based in Wisconsin, has raised $14 million so far and is seeking another $5 million. Item

> Rosetta Genomics, which is based in Philadelphia and Israel, just raised $27.5 million through a public offering of 5.5 million shares. Item

> Theragenics ($TGX) reported a 30% drop in profits in the second quarter, despite a 2.3% rise in revenue. More

> Chembio Diagnostics reported a second-quarter income boost of 58%, with sales climbing 68% over the same period last year. Release

Biotech News

 @FierceBiotech: Pfizer taps biotech startup to tailor R&D of lupus, autoimmune drugs More | Follow @FierceBiotech

 @JohnCFierce: Old pharma guys never die. They just go into venture capital. Now it's Jeff Kindler's turn. More | Follow @JohnCFierce

 @RyanMFierce: Buzz on the street: Who thinks Icahn can succeed in biotech without two aces, Denner and Mulligan? More | Follow @RyanMFierce

> Pfizer taps biotech startup to tailor R&D of lupus, autoimmune drugs. Article

> Amgen ditches PhIII effort for drug against pancreatic cancer. News

> Cancer stem cells prove tough IPO sell for Stemline. Article

> Merck hits the brakes on combo cholesterol drug. Story

Pharma News

 @FiercePharma: HBR has an interesting piece by Pfizer's Susan Silbermann, on sales strategies in Latin America. More | Follow @FiercePharma

> With patent clock ticking, Amgen plans to shutter Epogen plant. News

> High-flying Victoza sales push Novo's forecasts up. Story

Vaccines News

> Sanofi readies defense as judge rules antitrust lawsuit can proceed. Story

> Tuberculosis vaccine may reverse Type 1 diabetes. Item

> Immatics' kidney cancer vaccine extends lives in trials. News

> Researchers discover malaria target. Article

> FDA lifts hold on Allergy Therapeutics' grass pollen allergy vax. Story

> CDC preps for emerging swine flu strain. More

Pharma Manufacturing News

> FDA tells drugmaker quality can't be added after production. More

> Chinese firm nailed with import alert over unsanitary plant. News

> Amgen to idle Epogen plant as sales fade away. Story

Suggested Articles

Medtronic has moved to acquire Avenu Medical, developers of a minimally invasive method of building the blood vessel access ports.

The agency also gave the company’s diagnostic, run on the high-throughput Panther Fusion laboratory platform, a green light for pooled testing.

Smith & Nephew has signed up to acquire Integra LifeSciences’ orthopedics business focused on the growing upper and lower extremity markets.